T. Rowe Price Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $53.9M | Sell |
|
|||||
|
2022
Q2 | $76M | Buy |
|
|||||
|
2022
Q1 | $61.2M | Buy |
|
|||||
|
2021
Q4 | $64.2M | Buy |
|
|||||
|
2021
Q3 | $58.9M | Buy |
|
|||||
|
2021
Q2 | $36M | Buy |
|
|||||
|
2021
Q1 | $10.6M | Sell |
|
|||||
|
2020
Q4 | $13.3M | Buy |
|
|||||
|
2020
Q3 | $1.68M | Buy |
|
|||||
|
2020
Q2 | $1.86M | Sell |
|
|||||
|
2020
Q1 | $893K | Buy |
|
|||||
|
2019
Q4 | $1.4M | Buy |
|
|||||
|
2019
Q3 | $957K | Buy |
|
|||||
|
2019
Q2 | $825K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $10.1M | Buy |
|
|||||
|
2017
Q3 | $14M | Sell |
|
|||||
|
2017
Q2 | $12.4M | Buy |
|